As the 2026 fiscal year nears, significant regulatory changes are set to redefine the pricing landscape for the most costly ...

WASHINGTON, DC / ACCESS Newswire / March 24, 2026 / A new federal initiative allowing up to $500 annually in hemp-derived cannabinoid products for Medicare beneficiaries is raising urgent questions ...

Industry stakeholders hit Capitol Hill the week of March 9 for a series of high‑level meetings aimed at convincing the ...

The history of HCBS demonstrates that its growth is not, in fact, evidence of massive undetected fraud, but rather is based ...